熱門資訊> 正文
LIXTE Biotechnology注册直接发行价格为1，660万美元
2026-06-03 21:04
- LIXTE Biotechnology Holdings (NASDAQ: LIXT) on Wednesday said it entered into definitive agreements with accredited investors for a registered direct offering expected to raise approximately $16.6 million in gross proceeds.
- The offering consists of 2.63 million shares of common stock and pre-funded warrants, priced at $6.31 per share and $6.3099 per pre-funded warrant.
- The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 per share and remain exercisable until fully exercised.
- LIXTE said the transaction is expected to close on or about June 3, subject to customary closing conditions.
- The company plans to use the net proceeds, together with existing cash, for general corporate purposes, working capital, and strategic initiatives.
- Source: Press Release
More on Lixte Biotechnology Holdings, Inc.
- Financial information for Lixte Biotechnology Holdings, Inc.
推薦文章
美股前瞻 | 比特幣一度突破7.8萬美元！加密貨幣概念股盤前齊升；存儲需求強勁！美光CEO稱「全力生產也跟不上需求」
銀色債券2026今起認購！保底息率4.25釐，每手3年累計派息至少1,275港元
華盛早報 | 貝森特兩日救市！美債回購規模或超40億美元；Anthropic衝擊史上最大IPO；恆指季檢結果，中際旭創、長飛光纖財報今日公佈
美股前瞻 | 史詩級「軋空」來襲！比特幣升破7.2萬美元；業績股齊遇冷！沃爾瑪盤前大跌逾6%，阿里、網易均跌近4%
一圖看懂 | AI與雲業務表現強勁！阿里Q1營收2690億元，同比增9%略超預期；阿里雲外部商業化收入加速增至45%
一圖看懂 | 泡泡瑪特上半年營收171億、淨利50億均大遜預期！星星人IP逆勢暴漲580%；王寧稱計劃半年內大額回購20-50億
Moderna暴漲177%！mRNA癌症疫苗迎來「ChatGPT時刻」？16只港美標的誰會接過下一棒？
「影子股」已暴漲90%！如何在Anthropic史上最大IPO前搶跑入局？最全攻略來了
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
